GS-0201 / Gilead - LARVOL DELTA

Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=248 | Recruiting | Sponsor: Gilead Sciences | Not yet recruiting ➔ Recruiting

Enrollment open • Metastases • Monotherapy • Oncology • Solid Tumor • Triple Negative Breast Cancer

Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=248 | Not yet recruiting | Sponsor: Gilead Sciences

New P1 trial • Oncology • Solid Tumor • Triple Negative Breast Cancer